Neutrophil Paralysis in Plasmodium vivax Malaria


Autoria(s): de Souza Leoratti, Fabiana Maria; Trevelin, Silvia Cellone; Cunha, Fernando Queiroz; Rocha, Bruno Coelho; Carvalho Costa, Pedro Augusto; Gravina, Humberto Doriguetto; Tada, Mauro Shugiro; Pereira, Dhelio Batista; Golenbock, Douglas Taylor; do Valle Antonelli, Lis Ribeiro; Gazzinelli, Ricardo T.
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

05/11/2013

05/11/2013

2012

Resumo

Background: The activation of innate immune responses by Plasmodium vivax results in activation of effector cells and an excessive production of pro-inflammatory cytokines that may culminate in deleterious effects. Here, we examined the activation and function of neutrophils during acute episodes of malaria. Materials and Methods: Blood samples were collected from P. vivax-infected patients at admission (day 0) and 30-45 days after treatment with chloroquine and primaquine. Expression of activation markers and cytokine levels produced by highly purified monocytes and neutrophils were measured by the Cytometric Bead Assay. Phagocytic activity, superoxide production, chemotaxis and the presence of G protein-coupled receptor (GRK2) were also evaluated in neutrophils from malaria patients. Principal Findings: Both monocytes and neutrophils from P. vivax-infected patients were highly activated. While monocytes were found to be the main source of cytokines in response to TLR ligands, neutrophils showed enhanced phagocytic activity and superoxide production. Interestingly, neutrophils from the malaria patients expressed high levels of GRK2, low levels of CXCR2, and displayed impaired chemotaxis towards IL-8 (CXCL8). Conclusion: Activated neutrophils from malaria patients are a poor source of pro-inflammatory cytokines and display reduced chemotactic activity, suggesting a possible mechanism for an enhanced susceptibility to secondary bacterial infection during malaria.

National Institutes of Health

National Institutes of Health [R21 AI080907, RO1 AI079293]

Malaria Network [CNPq-555646/2009-2/FAPEMIG/MS-CBB-APQ-01153-10]

Malaria Network

National Institute of Science and Technology for Vaccines

National Institute of Science and Technology for Vaccines [CNPq-573547/2008-4/FAPEMIG/MS-CBB-APQ 00077-09]

Program for Technological Development in Tools for Health from Fundacao Oswaldo Cruz [PDTIS-FIOCRUZ-RVR22]

Program for Technological Development in Tools for Health from Fundacao Oswaldo Cruz

Identificador

PLOS NEGLECTED TROPICAL DISEASES, SAN FRANCISCO, v. 6, n. 6, supl. 4, Part 1-2, pp. 2323-2329, JUN, 2012

1935-2735

http://www.producao.usp.br/handle/BDPI/41599

10.1371/journal.pntd.0001710

http://dx.doi.org/10.1371/journal.pntd.0001710

Idioma(s)

eng

Publicador

PUBLIC LIBRARY SCIENCE

SAN FRANCISCO

Relação

PLOS NEGLECTED TROPICAL DISEASES

Direitos

openAccess

Copyright PUBLIC LIBRARY SCIENCE

Palavras-Chave #COUPLED RECEPTOR KINASES #TOLL-LIKE RECEPTOR-4 #FALCIPARUM-MALARIA #POLYMICROBIAL SEPSIS #CHEMOKINE RECEPTORS #DENDRITIC CELLS #T-CELLS #EXPRESSION #HEMOZOIN #ACTIVATION #INFECTIOUS DISEASES #PARASITOLOGY #TROPICAL MEDICINE
Tipo

article

original article

publishedVersion